Touyun Biotech Group Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.06	16.32	34.49	128.1	60.2
Short-Term Investments	-	3.87	7.53	6.2	5.91
Trading Asset Securities	-	53.33	1.54	16.16	33.76
Cash & Short-Term Investments	5.06	73.51	43.56	150.45	99.87
Cash Growth	-93.11%	68.75%	-71.05%	50.65%	-61.92%
Accounts Receivable	9.46	22.28	27.14	41.45	66.29
Other Receivables	0.97	27.28	27.28	26.49	26.13
Receivables	26.06	64.8	96.97	131.96	132.46
Inventory	18.24	24.59	15.25	35.61	32.77
Prepaid Expenses	48.98	4.21	2.87	3.99	3.12
Other Current Assets	-	6.94	3.83	-	-
Total Current Assets	98.35	174.05	162.48	322.01	268.22
Property, Plant & Equipment	242.19	280.18	310.63	381.28	435.95
Long-Term Investments	278.97	95.9	134.03	184.13	318.94
Other Intangible Assets	-	-	-	0.28	0.66
Long-Term Deferred Charges	-	-	-	-	0.97
Total Assets	619.7	550.32	607.34	887.7	1,025
Accounts Payable	7.81	12.53	17.96	28.32	37.88
Accrued Expenses	-	18.89	16.91	15.49	12.15
Short-Term Debt	99.05	99.36	94.39	284.35	388.87
Current Portion of Long-Term Debt	409.74	339.32	164.89	-	-
Current Portion of Leases	3.53	10.13	14.46	12	14.41
Current Income Taxes Payable	0.17	0.17	0.51	4.14	2.17
Current Unearned Revenue	5.56	22.16	18.88	17.18	23.48
Other Current Liabilities	65.6	55.44	52.7	48.51	50.61
Total Current Liabilities	591.45	557.98	380.71	410	529.56
Long-Term Debt	-	26.81	191.45	191.29	-
Long-Term Leases	0.35	6.17	14.1	2.9	8.12
Other Long-Term Liabilities	0.51	-	-	-	-
Total Liabilities	592.31	590.96	586.27	604.19	537.68
Common Stock	112.24	112.24	112.24	112.24	112.24
Additional Paid-In Capital	-	1,908	1,908	1,908	1,908
Retained Earnings	-	-2,137	-2,061	-1,801	-1,608
Comprehensive Income & Other	-163.34	34.07	39.92	45.27	58.52
Total Common Equity	-51.1	-83.2	-0.85	263.96	469.92
Minority Interest	78.49	42.56	21.92	19.55	17.13
Shareholders' Equity	27.39	-40.64	21.07	283.51	487.05
Total Liabilities & Equity	619.7	550.32	607.34	887.7	1,025
Total Debt	512.68	481.78	479.3	490.55	411.41
Net Cash (Debt)	-507.61	-408.27	-435.74	-340.1	-311.54
Net Cash Per Share	-0.18	-0.15	-0.16	-0.12	-0.11
Filing Date Shares Outstanding	2,836	2,806	2,806	2,806	2,806
Total Common Shares Outstanding	2,836	2,806	2,806	2,806	2,806
Working Capital	-493.1	-383.93	-218.23	-87.99	-261.34
Book Value Per Share	-0.02	-0.03	-0.00	0.09	0.17
Tangible Book Value	-51.1	-83.2	-0.85	263.68	469.26
Tangible Book Value Per Share	-0.02	-0.03	-0.00	0.09	0.17
Buildings	-	175.81	174.32	167.34	-
Machinery	-	169.74	175.68	175.55	77.24
Construction In Progress	-	2.4	5.81	0.65	310.85
Leasehold Improvements	-	5.19	5.41	5.33	5.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.